Cargando…

An Interleukin 5 Mutant Distinguishes between Two Functional Responses in Human Eosinophils

Interleukin 5 (IL-5) is the key cytokine involved in regulating the production and many of the specialized functions of mature eosinophils including priming, adhesion, and survival. We have generated a point mutant of human IL-5, IL-5 (E12K), which is devoid of agonist activity in both a TF-1 cell p...

Descripción completa

Detalles Bibliográficos
Autores principales: McKinnon, Murray, Page, Kevin, Uings, Iain J., Banks, Martyn, Fattah, Dilniya, Proudfoot, Amanda E.I., Graber, Pierre, Arod, Christian, Fish, Richard, Wells, Timothy N.C., Solari, Roberto
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 1997
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2198963/
https://www.ncbi.nlm.nih.gov/pubmed/9207003
_version_ 1782148102129451008
author McKinnon, Murray
Page, Kevin
Uings, Iain J.
Banks, Martyn
Fattah, Dilniya
Proudfoot, Amanda E.I.
Graber, Pierre
Arod, Christian
Fish, Richard
Wells, Timothy N.C.
Solari, Roberto
author_facet McKinnon, Murray
Page, Kevin
Uings, Iain J.
Banks, Martyn
Fattah, Dilniya
Proudfoot, Amanda E.I.
Graber, Pierre
Arod, Christian
Fish, Richard
Wells, Timothy N.C.
Solari, Roberto
author_sort McKinnon, Murray
collection PubMed
description Interleukin 5 (IL-5) is the key cytokine involved in regulating the production and many of the specialized functions of mature eosinophils including priming, adhesion, and survival. We have generated a point mutant of human IL-5, IL-5 (E12K), which is devoid of agonist activity in both a TF-1 cell proliferation assay and a human eosinophil adhesion assay. However, IL-5 (E12K) is a potent and specific antagonist of both these IL-5–dependent functional responses. In both receptor binding and cross-linking studies the wild-type and IL-5 (E12K) mutant exhibit virtually identical properties. This mutant protein was unable to stimulate tyrosine phosphorylation in human eosinophils, and blocked the phosphorylation stimulated by IL-5. In contrast, IL-5 (E12K) is a full agonist in a human eosinophil survival assay, although with reduced potency compared to the wild-type protein. This IL-5 mutant enables us to clearly distinguish between two IL-5–dependent functional responses and reveals distinct mechanisms of receptor/cellular activation.
format Text
id pubmed-2198963
institution National Center for Biotechnology Information
language English
publishDate 1997
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-21989632008-04-16 An Interleukin 5 Mutant Distinguishes between Two Functional Responses in Human Eosinophils McKinnon, Murray Page, Kevin Uings, Iain J. Banks, Martyn Fattah, Dilniya Proudfoot, Amanda E.I. Graber, Pierre Arod, Christian Fish, Richard Wells, Timothy N.C. Solari, Roberto J Exp Med Article Interleukin 5 (IL-5) is the key cytokine involved in regulating the production and many of the specialized functions of mature eosinophils including priming, adhesion, and survival. We have generated a point mutant of human IL-5, IL-5 (E12K), which is devoid of agonist activity in both a TF-1 cell proliferation assay and a human eosinophil adhesion assay. However, IL-5 (E12K) is a potent and specific antagonist of both these IL-5–dependent functional responses. In both receptor binding and cross-linking studies the wild-type and IL-5 (E12K) mutant exhibit virtually identical properties. This mutant protein was unable to stimulate tyrosine phosphorylation in human eosinophils, and blocked the phosphorylation stimulated by IL-5. In contrast, IL-5 (E12K) is a full agonist in a human eosinophil survival assay, although with reduced potency compared to the wild-type protein. This IL-5 mutant enables us to clearly distinguish between two IL-5–dependent functional responses and reveals distinct mechanisms of receptor/cellular activation. The Rockefeller University Press 1997-07-07 /pmc/articles/PMC2198963/ /pubmed/9207003 Text en This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Article
McKinnon, Murray
Page, Kevin
Uings, Iain J.
Banks, Martyn
Fattah, Dilniya
Proudfoot, Amanda E.I.
Graber, Pierre
Arod, Christian
Fish, Richard
Wells, Timothy N.C.
Solari, Roberto
An Interleukin 5 Mutant Distinguishes between Two Functional Responses in Human Eosinophils
title An Interleukin 5 Mutant Distinguishes between Two Functional Responses in Human Eosinophils
title_full An Interleukin 5 Mutant Distinguishes between Two Functional Responses in Human Eosinophils
title_fullStr An Interleukin 5 Mutant Distinguishes between Two Functional Responses in Human Eosinophils
title_full_unstemmed An Interleukin 5 Mutant Distinguishes between Two Functional Responses in Human Eosinophils
title_short An Interleukin 5 Mutant Distinguishes between Two Functional Responses in Human Eosinophils
title_sort interleukin 5 mutant distinguishes between two functional responses in human eosinophils
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2198963/
https://www.ncbi.nlm.nih.gov/pubmed/9207003
work_keys_str_mv AT mckinnonmurray aninterleukin5mutantdistinguishesbetweentwofunctionalresponsesinhumaneosinophils
AT pagekevin aninterleukin5mutantdistinguishesbetweentwofunctionalresponsesinhumaneosinophils
AT uingsiainj aninterleukin5mutantdistinguishesbetweentwofunctionalresponsesinhumaneosinophils
AT banksmartyn aninterleukin5mutantdistinguishesbetweentwofunctionalresponsesinhumaneosinophils
AT fattahdilniya aninterleukin5mutantdistinguishesbetweentwofunctionalresponsesinhumaneosinophils
AT proudfootamandaei aninterleukin5mutantdistinguishesbetweentwofunctionalresponsesinhumaneosinophils
AT graberpierre aninterleukin5mutantdistinguishesbetweentwofunctionalresponsesinhumaneosinophils
AT arodchristian aninterleukin5mutantdistinguishesbetweentwofunctionalresponsesinhumaneosinophils
AT fishrichard aninterleukin5mutantdistinguishesbetweentwofunctionalresponsesinhumaneosinophils
AT wellstimothync aninterleukin5mutantdistinguishesbetweentwofunctionalresponsesinhumaneosinophils
AT solariroberto aninterleukin5mutantdistinguishesbetweentwofunctionalresponsesinhumaneosinophils
AT mckinnonmurray interleukin5mutantdistinguishesbetweentwofunctionalresponsesinhumaneosinophils
AT pagekevin interleukin5mutantdistinguishesbetweentwofunctionalresponsesinhumaneosinophils
AT uingsiainj interleukin5mutantdistinguishesbetweentwofunctionalresponsesinhumaneosinophils
AT banksmartyn interleukin5mutantdistinguishesbetweentwofunctionalresponsesinhumaneosinophils
AT fattahdilniya interleukin5mutantdistinguishesbetweentwofunctionalresponsesinhumaneosinophils
AT proudfootamandaei interleukin5mutantdistinguishesbetweentwofunctionalresponsesinhumaneosinophils
AT graberpierre interleukin5mutantdistinguishesbetweentwofunctionalresponsesinhumaneosinophils
AT arodchristian interleukin5mutantdistinguishesbetweentwofunctionalresponsesinhumaneosinophils
AT fishrichard interleukin5mutantdistinguishesbetweentwofunctionalresponsesinhumaneosinophils
AT wellstimothync interleukin5mutantdistinguishesbetweentwofunctionalresponsesinhumaneosinophils
AT solariroberto interleukin5mutantdistinguishesbetweentwofunctionalresponsesinhumaneosinophils